Microsoft Corporation

NASDAQ: MSFT
$415.54
+$0.54 (+0.1%)
Real Time Data Delayed 15 Min.

MSFT Articles

The top analyst upgrades, downgrades and initiations seen for Monday included Allscripts Healthcare Solutions, AmeriGas Partners, CVS Health, IMAX, Kraft Heinz, Marathon Oil, Microsoft and Pfizer.
Judging by the most shorted stocks traded on the Nasdaq between the January 15 and January 31 settlement dates, those sellers were focused on a few favorites.
The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell, ServiceNow and Tiffany.
Microsoft reported fiscal first-quarter results after markets closed Wednesday.
Microsoft is scheduled to release its fiscal second-quarter financial results after the markets close on Wednesday.
24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this week, including Apple, Exxon and Microsoft.
Judging by the most shorted stocks traded on the Nasdaq between the December 31 and January 15 settlement dates, those sellers were still accumulating some of their favorites.
IBM posted better-than-expected earnings, and the stock rallied. However, investors are not sold on the company's long-term prospects.
24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price. We have also added in some additional color on these companies as well.
Judging by the most shorted stocks traded on the Nasdaq between the December 14 and December 31 settlement dates, those sellers were focused on a few of their favorites.
Investors with a long-term view, those that can look past the recent volatility, can own these four stocks at very good entry points, given the recent selling. Plus with limited or no exposure to...
See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average in 2019.
The top analyst upgrades, downgrades and initiations seen on the last trading day of 2018 include Atmos Energy, CRISPR Therapeutics, CSX, Editas, Mallinckrodt, Microsoft, Sun Life and Ultragenyx.
Judging by the most shorted stocks traded on the Nasdaq between the November 30 and December 14 settlement dates, those sellers were mostly holding on for the ride.
These six Buy-rated stocks that have had a strong year and would be solid additions to portfolios for the end of 2018 and the beginning of 2019.